Guru Announces Answers, Adding New Generative AI Capabilities to Transform the Way Teams Discover Knowledge
With Answers, users will be able to connect Guru to their company’s apps and find…
With Answers, users will be able to connect Guru to their company’s apps and find…
CLEVELAND, May 17, 2023 (GLOBE NEWSWIRE) — SPR® Therapeutics announced the publication of a comprehensive…
CLEVELAND, May 17, 2023 (GLOBE NEWSWIRE) — SPR® Therapeutics announced the publication of a comprehensive…
LEHI, Utah, May 17, 2023 (GLOBE NEWSWIRE) — CancerVAX, developer of a breakthrough universal cancer…
Company showcasing breakthrough encryption-in-use solution at the annual show HACKENSACK, N.J., May 17, 2023 (GLOBE…
Numerous Clients, Including Willis & Associates Family Dentistry, Quickly Embracing New Technology NEWPORT BEACH, Calif.–(BUSINESS…
Tai Document Processor leverages industry-leading Ai to save brokers time and reduce data translation risks…
NAPLES, Fla., May 17, 2023 (GLOBE NEWSWIRE) — Intetics, a leading global technology company, announced…
Vancouver, British Columbia–(Newsfile Corp. – May 17, 2023) – Fandifi Technology Corp. (CSE: FDM) (OTCQB:…
Herzliya, Israel, May 17, 2023 – (ACN Newswire) – Namogoo, the leading Digital Journey Continuity…
Global game developers are invited to apply for early access to personalize player results, game…
Collaborative Environment Offers Interactive Opportunity to Preview New Products Including the Industries First Generative AI…
SCHAUMBURG, Ill.–(BUSINESS WIRE)–#Mac–VisionTek Products LLC, a leading provider of high-performance upgrades and accessories for PCs…
Benchtop REM-I Platform enables unprecedented insights into cell biology through scalable single cell imaging, high-dimensional…
85% of AppSec pros say ability to differentiate between real risks and noise is critical,…
85% of AppSec pros say ability to differentiate between real risks and noise is critical,…
BURLINGAME, Calif., May 17, 2023 (GLOBE NEWSWIRE) — Corvus Pharmaceuticals, Inc. (Nasdaq: CRVS), a clinical-stage…
BURLINGAME, Calif., May 17, 2023 (GLOBE NEWSWIRE) — Corvus Pharmaceuticals, Inc. (Nasdaq: CRVS), a clinical-stage…
UB-VV200 preclinical data highlight successful generation of TagCAR T cells, which demonstrate dose-dependent anti-tumor activity…
UB-VV200 preclinical data highlight successful generation of TagCAR T cells, which demonstrate dose-dependent anti-tumor activity…